Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Praticien-chercheur
10 articles scientifiques publiés — formation continue solide
Disponibilité géographique
3 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
78.3 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CDS MEDICAL AIME CESAIRE
26 R DE LA FERME, 93000 BOBIGNY
CDS MUNICIPAL HENRI WALLON
2 R DE LA REPUBLIQUE, 93700 DRANCY
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
CHI ROBERT BALLANGER
BD ROBERT BALLANGER, 93420 VILLEPINTE
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
International journal of dermatology · 2017
AbstractPyoderma gangrenosum (PG) is a sterile neutrophilic disorder that rarely affects children. Clinical, epidemiological, and therapeutic data on pediatric PG is poor as there are many newly reported associated diseases and drugs. This paper aims to review all recent available data on pediatric PG. A systematic review of the literature was conducted using Embase, Medline, and Cochrane databases. A total of 132 articles were included in the review. The most commonly reported underlying diseases in pediatric PG are inflammatory bowel diseases followed by hematologic disorders, vasculitis, immune deficiencies and Pyogenic Arthritis, Pyoderma gangrenosum and Acne (PAPA) syndrome. More than half of the cases occur with no underlying disease. The most frequently reported clinical presentation is multiple disseminated ulcers. Treatment should be tailored according to the underlying etiology. It includes systemic steroids, corticosteroid sparing agents such as dapsone and cyclosporine, and TNF‐alpha inhibitors such as adalimumab and infliximab. Response to treatment is high with cure rates reaching 90%. A high index of suspicion and a thorough workup are mandatory in the management of pediatric PG.
International journal of dermatology · 2016
SummarySplinter hemorrhages (SHs) of the nails represent a frequent although not specific clinical finding that has been associated with conditions of varying severity. However, to date, there is no single report of their characteristics and etiologies. The aim of this study is to guide clinical practice by reviewing all of the data concerning SH of the nails that have become available since the first description of this condition was published in 1923, with particular reference to all clinical features, associated medical conditions, pathogenesis, and necessary workup. PubMed and EMBASE were searched using the keywords “splinter” AND “hemorrhage*”; the only articles excluded were those studying SHs of the retina. Splinter hemorrhage is a frequent nail disorder that may be idiopathic, drug‐induced, or a sign of a dermatological disease, such as psoriasis and lichen planus, or a wide range of systemic disorders, the most important of which are infections and vasculitis. Clinicians and dermatologists should be aware of all the clinical features of both SH and associated medical conditions.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Journal of medical Internet research · 2025 · Journal Article
Zaghloul H, Fanous K, Ahmed L, Arabi M, et al.
International journal of dermatology · 2017 · Journal Article
Kechichian E, Haber R, Mourad N, El Khoury R, et al.
International journal of dermatology · 2016 · Journal Article
Haber R, Khoury R, Kechichian E, Tomb R
Journal of medical Internet research · 2025 · Journal Article
Zaghloul H, Fanous K, Ahmed L, Arabi M, et al.
International journal of dermatology · 2017 · Journal Article
Kechichian E, Haber R, Mourad N, El Khoury R, et al.
International journal of dermatology · 2016 · Journal Article
Haber R, Khoury R, Kechichian E, Tomb R
British journal of pain · 2023 · Journal Article
Smith T, Mansfield M, Hanson S, Welsh A, et al.
The patient · 2016 · Journal Article
Chiauzzi E, DasMahapatra P, Cochin E, Bunce M, et al.
European journal of cancer (Oxford, England : 1990) · 2024 · Journal Article
Ebstein E, Brocard P, Soussi G, Khoury R, et al.
Annals of internal medicine · 2024 · Journal Article
Denis G, Espitia O, Allix-Béguec C, Dieval C, et al.
BMJ open · 2023 · Clinical Trial Protocol
Smith T, Khoury R, Ashford PA, Hanson S, et al.
International journal of dermatology · 2017 · Journal Article
Kechichian E, Haber R, Mourad N, El Khoury R, et al.
Autoimmunity reviews · 2018 · Journal Article
Harifi G, Nour-Eldine W, Noureldine MHA, Berjaoui MB, et al.
Coronary artery disease · 2016 · Journal Article
Qiu F, Maehara A, El Khoury R, Généreux P, et al.